MTL-CEBPA, a small activating RNA therapeutic up-regulating C/EBP-α, in patients with advanced liver cancer: a first-in-human, multi-centre, open-label, phase I trial
published in: Clinical Cancer Research
date of publication: 2020-05-01
main subject: phase I clinical trial, liver cancer
Cites articles
There is nothing here
Article - wd:Q94482005